Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population

Human Immunology

Volumn 73, Issue 1, 2012, Pages 80-92

  Paximadis, Maria ^a   Mathebula, Tiyani Y ^a   Gentle, Nikki L ^a   Vardas, Eftyhia ^b   Colvin, Mark ^c   Gray, Clive M ^a   Tiemessen, Caroline T ^a   Puren, Adrian ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c Maromi Health Research   (South Africa)

Author keywords

Allotypes; Class I (A, B,C) and class II (DRB1) alleles; Haplotypes; HLA; South African population; Supertypes

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CAUCASIAN; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PHENOTYPE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DRB1 CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA;

EID: 84355161411     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.10.013     Document Type: Article

References (54)

1. Shiina T., Hosomichi K., Inoko H., Kulski J.K. The HLA genomic loci map: Expression, interaction, diversity and disease. J Hum Genet 2009, 54:15-39.
2. Lanier L.L. NK Cell Recognition. Annu Review Immunol 2005, 23:225-274.
3. Spurgin L.G., Richardson D.S. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc R Soc'Y Lond B Biol Sci 2010, 277:979-988.
4. Carrington M., O'Brien S.J. The Influence of HLA Genotype on AIDS*. Annu Review Med 2003, 54:535-551.
5. Rohowsky-Kochan C., Skurnick J., Molinaro D., Louria D. HLA antigens associated with susceptibility/resistance to HIV-1 infection. Hum Immunol 1998, 59:802-815.
6. Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., et al. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283:1748-1752.
7. Hendel H., Caillat-Zucman S., Lebuanec H., Carrington M., O'Brien S., Andrieu J.-M., et al. New class I and II HLA Alleles Strongly Associated with Opposite Patterns of Progression to AIDS. J Immunol 1999, 162:6942-6946.
8. Lajoie J., Hargrove J., Zijenah Lynn Â.S., Humphrey Jean Â.H., Ward Brian Â.J., Roger M. Genetic variants in nonclassical major histocompatibility Complex class I human leukocyte antigen (HLA)-E and HLA-G Molecules Are Associated with Susceptibility to Heterosexual Acquisition of HIV-1. J Infect Dis 2006, 193:298-301.
9. Solberg O.D., Mack S.J., Lancaster A.K., Single R.M., Tsai Y., Sanchez-Mazas A., et al. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies. Hum Immunol 2008, 69:443-464.
10. Smith W.P., Vu Q., Li S.S., Hansen J.A., Zhao L.P., Geraghty D.E. Toward understanding MHC disease associations: Partial resequencing of 46 distinct HLA haplotypes. Genomics 2006, 87:561-571.
11. Horton R., Gibson R., Coggill P., Miretti M., Allcock R.J., Almeida J., et al. Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. Immunogenetics 2008, 60:1-18.
12. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I Supertypes: A revised and updated classification. BMC Immunol 2008, 9:1.
13. Naugler C. Origins and relatedness of human leukocyte antigen class I allele Supertypes. Hum Immunol 2010, 71:837-842.
14. MacDonald K.S., Fowke K.R., Kimani J., Dunand V.A., Nagelkerke N.J.D., Ball T.B., et al. Influence of HLA Supertypes on susceptibility and resistance to human immunodeficiency virus type 1 Infection. J Infect Dis 2000, 181:1581-1589.
15. Lazaryan A., Lobashevsky E., Mulenga J., Karita E., Allen S., Tang J., et al. Human leukocyte antigen B58 Supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 2006, 80:6056-6060.
16. Tiemessen C.T., Shalekoff S., Meddows-Taylor S., Schramm D.B., Papathanasopoulos M.A., Gray G.E., et al. Cutting edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol 2009, 182:5914-5918.
17. Tiemessen C.T., Shalekoff S., Meddows-Taylor S., Schramm D.B., Papathanasopoulos M.A., Gray G.E., et al. Natural killer cells that respond to human immunodeficiency virus type 1(HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis 2010, 202:1444-1453.
18. Müller C.A., Engler-Blum G., Gekeler V., Steiert I., Weiss E., Schmidt H. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 1989, 30:200-207.
19. Cella M., Longo A., Ferrara G.B., Strominger J.L., Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994, 180:1235-1242.
20. Bjorkman P.J., Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990, 59:253-288.
21. Uitenbroek D.G. SISA Binomial Southampton: DG Uitenbroek, Accessed January 1, 2004. http://www.quantitativeskills.com/sisa/distributions/binomial.htm.
22. Lancaster A., Nelson M.P., Meyer D., Thomson G., Single R.M. PyPop: A software framework for population genomics: Analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 2003, 514-525.
23. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992, 48:361-372.
24. Hedrick P.W. Gametic disequilibrium measures: Proceed with caution. Genetics 1987, 117:331-341.
25. Lewontin R.C. The interaction of selection and linkage. I. General considerations; heterotic Models. Genetics 1964, 49:49-67.
26. Lewontin R.C. The interaction of selection and linkage. II. Optimum models. Genetics 1964, 50:757-782.
27. Liau S.W., Mickey R., Romano P., Lee T.D. Study of the HLA system in the Haitian population. Tissue Antigens 1984, 23:308-313.
28. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system, 2004. Tissue Antigens 2005, 65:301-369.
29. Lombard Z., Dalton D.L., Venter P.A., Williams R.C., Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol 2006, 67:643-654.
30. Meyer D., Singe R.M., Mack S.J., Lancaster A., Nelson M., Erlich H., et al. Single locus polymorphism of classical HLA genes. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference 2007, Vol I:653-704. J.A. Hansen (Ed.).
31. Middleton D., Williams F., Meenagh A., Daar A.S., Gorodezky C., Hammond M., et al. Analysis of the distribution of HLA-A alleles in populations from five continents. Hum Immunol 2000, 61:1048-1052.
32. Williams F., Meenagh A., Darke C., Acosta A., Daar A.S., Gorodezky C., et al. Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol 2001, 62:645-650.
33. Baena A., Leung J.Y., Sullivan A.D., Landires I., Vasquez-Luna N., Quiñones-Berrocal J., et al. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002, 3:482-487.
34. Hammer M.F., Spurdle A.B., Karafet T., Bonner M.R., Wood E.T., Novelletto A., et al. The geographic distribution of human Y chromosome variation. Genetics 1997, 145:787-805.
35. Zietkiewicz E., Yotova V., Jarnik M., Korab-Laskowska M., Kidd K.K., Modiano D., et al. Nuclear DNA diversity in worldwide distributed human populations. Gene 1997, 205:161-171.
36. Levene H. On a matching problem arising in genetics. Ann Math Stat 1949, 20:91-94.
37. Nei M., Roychoudhury A.K. Sampling variances of heterozygosity and genetic distance. Genetics 1974, 76:379-390.
38. Chen J.J., Hollenbach J.A., Trachtenberg E.A., Just J.J., Carrington M., Rønningen K.S., et al. Hardy-Weinberg testing for HLA class II (DRB1, DQA1, DQB1, and DPB1) loci in 26 human ethnic groups. Tissue Antigens 1999, 54:533-542.
39. Middleton D., Menchaca L., Rood H., Komerofsky R. New allele frequency database. Tissue Antigens 2003, 61:403-407. http://www.allelefrequencies.net.
40. Barbour J.D., Sriram U., Caillier S.J., Levy J.A., Hecht F.M., Oksenberg J.R. Synergy or independence?. Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog 2007, 3:e43.
41. Boulet S., Kleyman M., Kim J.Y., Kamya P., Sharafi S., Simic N., et al. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 2008, 22:1487-1491.
42. Boulet S., Sharafi S., Simic N., Bruneau J., Routy J.P., Tsoukas C.M., et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008, 22:595-599.
43. Gaudieri S., DeSantis D., McKinnon E., Moore C., Nolan D., Witt C.S., et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 2005, 6:683-690.
44. Jennes W., Verheyden S., Demanet C., Adjé-Touré C.A., Vuylsteke B., Nkengasong J.N., et al. Cutting edge: Resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006, 177:6588-6592.
45. López-Vázquez A., Miña-Blanco A., Martínez-Borra J., Njobvu P.D., Suárez-Alvarez B., Blanco-Gelaz M.A., et al. Interaction between KIR3DL1 and HLA-B*57 Supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol 2005, 66:285-289.
46. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 31:429-434.
47. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740.
48. Huang X., Ling H., Mao W., Ding X., Zhou Q., Han M., et al. Association of HLA-A, B, DRB1 alleles and haplotypes with HIV-1 infection in Chongqing, China. BMC Infect Dis 2009, 9:201.
49. Lacap P.A., Huntington J.D., Luo M., Nagelkerke N.J., Bielawny T., Kimani J., et al. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort. AIDS 2008, 22:1029-1038.
50. Tang J., Tang S., Lobashevsky E., Myracle A.D., Fideli U., Aldrovandi G., et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002, 76:8276-8284.
51. Leslie A., Matthews P.C., Listgarten J., Carlson J.M., Kadie C., Ndungu T., et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010, 84:9879-9888.
52. Cao K., Moormann A.M., Lyke K.E., Masaberg C., Sumba O.P., Doumbo O.K., et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004, 63:293-325.
53. Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., et al. Advantage of rare HLA Supertype in HIV disease progression. Nat Med 2003, 9:928-935.
54. Lazaryan A., Song W., Lobashevsky E., Tang J., Shrestha S., Zhang K., et al. Human leukocyte antigen class I Supertypes and HIV-1 control in African Americans. J Virol 2010, 84:2610-2617.